pharma biotech

Wall Street turned sharply active in early February 2026, with analysts rotating through five very different stories — Enphase Energy, Cloudflare, Merck & Co., Microsoft, and fuboTV — issuing upgrades, downgrades and much‑debated price targets that together illuminate how investors are...